Stocktoria
Xenon Pharmaceuticals Inc. XENE
Xenon Pharmaceuticals Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 2,886,390 | $167.8M | 3.61% |
| BlackRock Finance, Inc. | 2,095,894 | $81.7M | 2.62% |
| TWO SIGMA INVESTMENTS, LP | 606,085 | $35.2M | 0.76% |
| RENAISSANCE TECHNOLOGIES LLC | 300,500 | $17.5M | 0.38% |
| MILLENNIUM MANAGEMENT LLC | 201,785 | $11.7M | 0.25% |
| D. E. Shaw & Co., Inc. | 38,740 | $2.3M | 0.05% |
| Point72 Asset Management, L.P. | 18,600 | $1.1M | 0.02% |
| AQR CAPITAL MANAGEMENT LLC | 7,279 | $423,274 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.